Mickisch GH - Search Results

1

Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer.

Van Brussel JP, Jan Van Steenbrugge G, Van Krimpen C, Bogdanowicz JF, Van Der Kwast TH, Schröder FH, Mickisch GH. Van Brussel JP, et al. Among authors: mickisch gh. J Urol. 2001 Jan;165(1):130-5. doi: 10.1097/00005392-200101000-00032. J Urol. 2001. PMID: 11125381

2

Circumvention of multidrug resistance in genitourinary tumors.

van Brussel JP, Mickisch GH. van Brussel JP, et al. Among authors: mickisch gh. Int J Urol. 1998 Jan;5(1):1-15. doi: 10.1111/j.1442-2042.1998.tb00226.x. Int J Urol. 1998. PMID: 9535594 Free article. Review.

3

Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins.

van Brussel JP, van Steenbrugge GJ, Romijn JC, Schröder FH, Mickisch GH. van Brussel JP, et al. Among authors: mickisch gh. Eur J Cancer. 1999 Apr;35(4):664-71. doi: 10.1016/s0959-8049(98)00435-3. Eur J Cancer. 1999. PMID: 10492644

4

Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.

Scheltema JM, Romijn JC, van Steenbrugge GJ, Schröder FH, Mickisch GH. Scheltema JM, et al. Among authors: mickisch gh. Anticancer Res. 2001 Sep-Oct;21(5):3161-6. Anticancer Res. 2001. PMID: 11848468

5

Spontaneous remission of a bony metastasis in prostatic adenocarcinoma.

Schurmans JR, Blijenberg BG, Mickisch GH, Schröder FH. Schurmans JR, et al. Among authors: mickisch gh. J Urol. 1996 Feb;155(2):653. J Urol. 1996. PMID: 8558693 Free article. No abstract available.

6

Multidrug resistance in prostate cancer.

van Brussel JP, Mickisch GH. van Brussel JP, et al. Among authors: mickisch gh. Onkologie. 2003 Apr;26(2):175-81. doi: 10.1159/000071510. Onkologie. 2003. PMID: 12771527 Review.

7

Identification of multidrug resistance-associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine.

van Brussel JP, Oomen MA, Vossebeld PJ, Wiemer EA, Sonneveld P, Mickisch GH. van Brussel JP, et al. Among authors: mickisch gh. BJU Int. 2004 Jun;93(9):1333-8. doi: 10.1111/j.1464-410X.2004.04847.x. BJU Int. 2004. PMID: 15180633

8

Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial.

Verhagen PC, Wildhagen MF, Verkerk AM, Vjaters E, Pagi H, Kukk L, Bratus D, Fiala R, Bangma CH, Schröder FH, Mickisch GH. Verhagen PC, et al. Among authors: mickisch gh. World J Urol. 2014 Oct;32(5):1287-94. doi: 10.1007/s00345-013-1206-0. Epub 2013 Nov 21. World J Urol. 2014. PMID: 24258313 Clinical Trial.

9

The artificial urinary sphincter in men incontinent after radical prostatectomy: 5 year actuarial adequate function rates.

Klijn AJ, Hop WC, Mickisch G, Schröder FH, Bosch JL. Klijn AJ, et al. Br J Urol. 1998 Oct;82(4):530-3. doi: 10.1046/j.1464-410x.1998.00807.x. Br J Urol. 1998. PMID: 9806182

10

Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinoma.

Mickisch GH, Noordzij MA, vd Gaast A, Gebreamlack P, Köhrmann KU, Mogler-Drautz E, Kupper H, Schröder FH. Mickisch GH, et al. J Cancer Res Clin Oncol. 1995;121 Suppl 3:R11-6. doi: 10.1007/BF02351065. J Cancer Res Clin Oncol. 1995. PMID: 8698736 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters